Harmony Biosciences Holdings, Inc. Net Income 2019–2025
Harmony Biosciences Holdings, Inc. reported $158.69M of net income for fiscal 2025. That was 9.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +529.5%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $158.69M | 18.3% | +9.1% |
| FY 2024 | $145.49M | 20.4% | +12.9% |
| FY 2023 | $128.85M | 22.1% | -29.0% |
| FY 2022 | $181.47M | 41.4% | +424.5% |
| FY 2021 | $34.60M | 11.3% | +193.6% |
| FY 2020 | $-36.94M | -23.1% | +75.7% |
| FY 2019 | $-151.98M | -2535.1% | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HRMY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Harmony Biosciences Holdings, Inc. reported $158.69M of net income for fiscal 2025. That was 9.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +529.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s net income?
Harmony Biosciences Holdings, Inc. (HRMY) reported net income of $158.69M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.